Evidence map›Paper›PMID 29389224›Full record

ArticleJournal of palliative medicine2018

Perspectives on Palliative Care in Cancer Clinical Trials: Diverse Meanings from Multidisciplinary Cancer Care Providers.

Michelle A Mollica, Erin E Kent, Kathleen M Castro, Erin M Ellis, Rebecca A Ferrer, Angela L Falisi, Anna Gaysynsky, Grace C Huang, Martha A Palan, Wen-Ying Sylvia Chou

Abstract read
In one paragraph

Article in Journal of palliative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Frequency of anticancer drug use at the end of life: a scoping review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michelle A Mollica1 Division of Cancer Control and Population Sciences, National Cancer Institute , NIH, Bethesda, Maryland.
Erin E Kent1 Division of Cancer Control and Population Sciences, National Cancer Institute , NIH, Bethesda, Maryland.
Kathleen M Castro1 Division of Cancer Control and Population Sciences, National Cancer Institute , NIH, Bethesda, Maryland.
Erin M Ellis1 Division of Cancer Control and Population Sciences, National Cancer Institute , NIH, Bethesda, Maryland.
Rebecca A Ferrer1 Division of Cancer Control and Population Sciences, National Cancer Institute , NIH, Bethesda, Maryland.
Angela L Falisi1 Division of Cancer Control and Population Sciences, National Cancer Institute , NIH, Bethesda, Maryland.
Anna Gaysynsky2 ICF International, Inc. , Rockville, Maryland.
Grace C Huang3 Westat, Inc. , Rockville, Maryland.
Martha A Palan3 Westat, Inc. , Rockville, Maryland.
Wen-Ying Sylvia Chou1 Division of Cancer Control and Population Sciences, National Cancer Institute , NIH, Bethesda, Maryland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPalliative care (PC) is often misunderstood as exclusively pertaining to end-of-life care, which may be consequential for its delivery. There is little research on how PC is operationalized and delivered to cancer patients enrolled in clinical trials.

objectiveWe sought to understand the diverse perspectives of multidisciplinary oncology care providers caring for such patients in a teaching hospital.

methodsWe conducted qualitative semistructured interviews with 19 key informants, including clinical trial principal investigators, oncology fellows, research nurses, inpatient and outpatient nurses, spiritual care providers, and PC fellows. Questions elicited information about the meaning providers assigned to the term "palliative care," as well as their experiences with the delivery of PC in the clinical trial context. Using grounded theory, a team-based coding method was employed to identify major themes.

resultsFour main themes emerged regarding the meaning of PC: (1) the holistic nature of PC, (2) the importance of symptom care, (3) conflict between PC and curative care, and (4) conflation between PC and end-of-life care. Three key themes emerged with regard to the delivery of PC: (1) dynamics among providers, (2) discussing PC with patients and family, and (3) the timing of PC delivery.

conclusionThere was great variability in personal meanings of PC, conflation with hospice/end-of-life care, and appropriateness of PC delivery and timing, particularly within cancer clinical trials. A standard and acceptable model for integrating PC concurrently with treatment in clinical trials is needed.

Indexed as

AdultAttitude of Health PersonnelClinical Trials as TopicFemaleHealth PersonnelHospice and Palliative Care NursingHumansInterdisciplinary StudiesMaleMiddle AgedPractice Guidelines as TopicQualitative ResearchTerminal Careclinical trialsoncologypalliative care

Identifiers

PMID29389224
PMCPMC6016720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.